Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kejin Wu

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Pageof 5